<DOC>
	<DOCNO>NCT00135655</DOCNO>
	<brief_summary>The purpose study investigate safety tolerability three dose strength study drug subject post cataract extraction macular edema .</brief_summary>
	<brief_title>A Study Denufosol Tetrasodium Intravitreal Injection Subjects With Post Cataract Extraction Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Have persistent post cataract extraction macular edema whose condition stable Have change medication regimen immunosuppressive antiinflammatory agent ; steroidal nonsteroidal agent specified period time prior randomization Have least one eligible eye treat study Have optical coherence tomography ( OCT ) scan qualify retinal thickness study eye Have macular edema confirm fluorescein angiography Have proliferative vitreoretinopathy great grade B either eye Have ocular disorder study eye may confound interpretation study result Have ophthalmic disorder study eye may influence final visual acuity and/or fluorescein angiography interpretation Have cataract surgery study eye past 2 month , YAG laser capsulotomy within past 1 month , intraocular surgery within past 90 day Have uncontrollable elevate intraocular pressure ( IOP ) advance glaucoma Have periocular intravitreal injection corticosteroid study eye within 3 month Have ocular implant device delivery therapeutic agent Be take excluded medication could obscure confound study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>macular edema</keyword>
	<keyword>post cataract extraction</keyword>
	<keyword>cystoid macular edema</keyword>
	<keyword>post cataract extraction macular edema</keyword>
</DOC>